Skip to main content
David D'Alessio, MD, Endocrinology, Durham, NC, Duke University Hospital

DavidAD'AlessioMD

Endocrinology Durham, NC

Diabetes, Lipid Metabolism

Director, Division of Endocrinology, Duke University Medical Center

Dr. D'Alessio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. D'Alessio's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
  • Temple University Hospital
    Temple University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1987
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1983 - 1986
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1983
  • Carleton College
    Carleton CollegeBA, Biology, 1975 - 1979

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2014 - 2024
  • VA State Medical License
    VA State Medical License 1986 - 2016
  • OH State Medical License
    OH State Medical License 1999 - 2015
  • WA State Medical License
    WA State Medical License 1987 - 1999
  • PA State Medical License
    PA State Medical License 1984 - 1988
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Endocrinology Teaching Award Duke University, 2016
  • Paul Beeson Award for Clinical Teaching University of Washington, 1998
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Acute administration of acyl, but not desacyl ghrelin, decreases blood pressure in healthy humans  
    Zhang CJ, Bidlingmaier M, Altaye M, Page LC, D'Alessio D, Tschop MH, Tong J, Eur J Endocrinol, 1/1/2017
  • Disruption of Glucagon-Like Peptide 1 Signaling in Sim1 Neurons Reduces Physiological and Behavioral Reactivity to Acute and Chronic Stress  
    Ghosal S, Packard AE, Mahbod P, McKlveen JM, Seeley RJ, Myers B, Ulrich-Lai Y, Smith EP, D'Alessio DA, Herman JP, J Neurosci, 1/1/2017
  • The incretin effect in obese adolescents with and without type 2 diabetes: Impaired or intact?  
    Aulinger BA, Vahl TP, Prigeon RL, D'Alessio DA, Elder DA, Am J Physiol Endocrinol Metab, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Press Mentions

  • A Few Words of Introduction from Your New Diabetes Editorial Board
    A Few Words of Introduction from Your New Diabetes Editorial BoardMarch 4th, 2016

Hospital Affiliations